During the past decade, Institutul de Neurologie si Neurochirurgie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Institutul de Neurologie si Neurochirurgie" are "Multiple Sclerosis" (2 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Institutul de Neurologie si Neurochirurgie" in a lesser frequency.

Most popular intervention types in "Institutul de Neurologie si Neurochirurgie" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Interferon beta-1a" (2 trials), "Ozanimod" (2 trials), "Interferon beta-1a placebo" (1 trials), "Ozanimod placebo" (1 trials) and "Placebo to interferon beta-1a" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institutul de Neurologie si Neurochirurgie" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Institutul de Neurologie si Neurochirurgie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Institutul de Neurologie si Neurochirurgie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institutul de Neurologie si Neurochirurgie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".